- Home
- INBX vs DXYZ Comparison
INBX vs DXYZ Comparison
Compare INBX & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | DXYZ |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INBX | DXYZ |
|---|---|---|
| Price | $93.58 | $27.70 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $150.00 | N/A |
| AVG Volume (30 Days) | 331.5K | ★ 3.1M |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $20.55 | $19.71 |
| 52 Week High | $155.29 | $72.87 |
Technical Indicators
Market Signals| Indicator | INBX | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 42.99 |
| Support Level | $85.94 | $23.96 |
| Resistance Level | $96.12 | $29.69 |
| Average True Range (ATR) | 7.44 | 1.69 |
| MACD | 0.78 | 0.70 |
| Stochastic Oscillator | 33.00 | 65.92 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About DXYZ Destiny Tech100 Inc.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.